Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR’), Camlin Fine Sciences has informed that it enclosed the schedule of Analyst or Investor Meeting(s) to discuss about the Company’s business and about the industry. The dates of the scheduled call(s) are subject to change due to exigencies on the part of Investors/Company. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. Take the above on record and the same be treated as compliance under the applicable Regulations of SEBI LODR.
The above information is a part of company’s filings submitted to BSE.
